Literature DB >> 35533300

Mutation of Methionine to Asparagine but Not Leucine in Parathyroid Hormone Mimics the Loss of Biological Function upon Oxidation.

Amit Gaur1, Jessica Lipponen1, Yanmei Yang1, Roger S Armen2, Bin Wang1.   

Abstract

Human parathyroid hormone (PTH) is an 84-amino acid peptide that contains two methionine (Met) residues located at positions 8 and 18. It has long been recognized that Met residues in PTH are subject to oxidation to become Met sulfoxide, resulting in a decreased biological function of the peptide. However, the mechanism of the lost biological function of PTH oxidation remains elusive. To characterize whether the shift from the hydrophobic nature of the native Met residue to the hydrophilic nature of Met sulfoxide plays a role in the reduction of biological activity upon PTH oxidation, we conducted in silico and in vitro site-directed mutagenesis of Met-8 and Met-18 to the hydrophilic residue asparagine (Asn) or to the hydrophobic residue leucine (Leu) and compared the behavior of these mutated peptides with that of PTH oxidized at Met-8 and/or Met-18. Our results showed that the biological activity of the Asn-8 and Asn-8/Asn-18 mutants was significantly reduced, similar to Met-8 sulfoxide and Met-8/Met-18 sulfoxide analogues, while the functions of Asn-18, Leu-8, Leu-8/Leu-18 mutants, or Met-18 sulfoxide analogues were similar to wild-type PTH. This is rationalized from molecular modeling and immunoprecipitation assay, demonstrating disruption of hydrophobic interactions between Met-8 and Met-18 of PTH and type-1 PTH receptor (PTHR1) upon mutation or oxidation. Thus, these novel findings support the notion that the loss of biological function of PTH upon oxidation of Met-8 is due, at least in part, to the conversion from a hydrophobic to a hydrophilic residue that disrupts direct hydrophobic interaction between PTH and PTHR1.

Entities:  

Year:  2022        PMID: 35533300      PMCID: PMC9179810          DOI: 10.1021/acs.biochem.2c00200

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.321


  30 in total

1.  Minimization of parathyroid hormone. Novel amino-terminal parathyroid hormone fragments with enhanced potency in activating the type-1 parathyroid hormone receptor.

Authors:  M Shimizu; J T Potts; T J Gardella
Journal:  J Biol Chem       Date:  2000-07-21       Impact factor: 5.157

2.  Structure and dynamics of the active human parathyroid hormone receptor-1.

Authors:  Li-Hua Zhao; Shanshan Ma; Ieva Sutkeviciute; Dan-Dan Shen; X Edward Zhou; Parker W de Waal; Chen-Yao Li; Yanyong Kang; Lisa J Clark; Frederic G Jean-Alphonse; Alex D White; Dehua Yang; Antao Dai; Xiaoqing Cai; Jian Chen; Cong Li; Yi Jiang; Tomoyuki Watanabe; Thomas J Gardella; Karsten Melcher; Ming-Wei Wang; Jean-Pierre Vilardaga; H Eric Xu; Yan Zhang
Journal:  Science       Date:  2019-04-12       Impact factor: 47.728

Review 3.  International Union of Basic and Clinical Pharmacology. XCIII. The parathyroid hormone receptors--family B G protein-coupled receptors.

Authors:  Thomas J Gardella; Jean-Pierre Vilardaga
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

4.  Oxidation of either methionine 351 or methionine 358 in alpha 1-antitrypsin causes loss of anti-neutrophil elastase activity.

Authors:  C Taggart; D Cervantes-Laurean; G Kim; N G McElvaney; N Wehr; J Moss; R L Levine
Journal:  J Biol Chem       Date:  2000-09-01       Impact factor: 5.157

Review 5.  Oxidative stress in chronic kidney disease.

Authors:  Kristien Daenen; Asmin Andries; Djalila Mekahli; Ann Van Schepdael; François Jouret; Bert Bammens
Journal:  Pediatr Nephrol       Date:  2018-08-13       Impact factor: 3.714

Review 6.  Targeting oxidative stress in disease: promise and limitations of antioxidant therapy.

Authors:  Henry Jay Forman; Hongqiao Zhang
Journal:  Nat Rev Drug Discov       Date:  2021-06-30       Impact factor: 84.694

7.  Toward the estimation of the absolute quality of individual protein structure models.

Authors:  Pascal Benkert; Marco Biasini; Torsten Schwede
Journal:  Bioinformatics       Date:  2010-12-05       Impact factor: 6.937

8.  Biased signaling of the proton-sensing receptor OGR1 by benzodiazepines.

Authors:  Tonio Pera; Deepak A Deshpande; Michael Ippolito; Bin Wang; Adelina Gavrila; James V Michael; Ajay P Nayak; Eric Tompkins; Eleni Farrell; Wesley K Kroeze; Bryan L Roth; Reynold A Panettieri; Jeffrey L Benovic; Steven S An; Nickolai O Dulin; Raymond B Penn
Journal:  FASEB J       Date:  2018-01-04       Impact factor: 5.834

9.  Ixazomib enhances parathyroid hormone-induced β-catenin/T-cell factor signaling by dissociating β-catenin from the parathyroid hormone receptor.

Authors:  Yanmei Yang; Hong Lei; Ya-Wei Qiang; Bin Wang
Journal:  Mol Biol Cell       Date:  2017-05-11       Impact factor: 4.138

10.  MolProbity: all-atom structure validation for macromolecular crystallography.

Authors:  Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.